Novel agents in mantle cell lymphoma. - Wikidata - awgldk - TriplyDB

Novel agents in mantle cell lymphoma.

Novel agents in mantle cell lymphoma.

http://www.wikidata.org/entity/Q38516704

about

FNC efficiently inhibits mantle cell lymphoma growth.Current trials for frontline therapy of mantle cell lymphoma.Rac1 is a novel therapeutic target in mantle cell lymphoma.

P2860

Q36319779-E85F8B23-03D9-4F3F-9792-CAD9A017CBB3 Q49279565-3EB92A82-867C-4537-9149-038D27CB85AE Q49659048-1C4E9337-B126-4CA5-9399-01E0BFD2AD41

P2860

Novel agents in mantle cell lymphoma.

http://www.wikidata.org/entity/Q38516704

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Novel agents in mantle cell lymphoma.

@en

type

label

Novel agents in mantle cell lymphoma.

@en

prefLabel

Novel agents in mantle cell lymphoma.

@en

P1433

Q38516704-E30A7BD8-1581-4653-B709-8B98E9946E57

P1476

Q38516704-FDB70D65-26F9-4140-AC88-283D2DCF2739

P2093

Q38516704-3A2F4730-CE9C-4333-80CE-19389BBAEEBD

P2860

Q38516704-031E77E8-DF39-40AE-A5AD-6A18343627DD

Q38516704-09BAD6AF-B837-4691-B998-7D646F14A05E

Q38516704-0DF3A541-B169-4172-A311-F20D44AE65F7

Q38516704-1278B774-A454-4D60-85B6-A47F5BA3B719

Q38516704-160F4131-36F6-4594-BD89-818B8394AA2D

Q38516704-1B184DC4-99E3-4E03-9097-7E2ACE13E5FD

Q38516704-20254BCF-C13F-459A-94CB-7810BEA91EDF

Q38516704-221C570F-2369-468D-A819-188517504112

Q38516704-2232908A-8E21-44F7-BF3D-BF6255673D3C

Q38516704-271499DC-24B0-4A33-BCC8-BB0F6303E39D

P2888

Q38516704-682E358F-3123-43F6-8BF5-0B42242A130B

P304

Q38516704-D15855B7-6B3F-421A-A973-539B128EDDF5

P31

Q38516704-33268BBC-F968-4B81-B752-ADEE63F56589

P356

Q38516704-E8004843-94C7-4779-8F25-08B0B3E6CF9B

P433

Q38516704-BDA8E41F-DCF4-432E-8B30-294D21829BE4

P478

Q38516704-C30FF8B9-DBDD-4990-9932-86C062D8FD72

P577

Q38516704-F8CEC765-E7D9-4B3B-A8A6-6BB00B624E24

P6179

Q38516704-70A2C999-9D3F-460B-85C1-9BF1248E36D1

P698

Q38516704-D7C4E46D-3E1A-452E-81A4-065DB1388087

P356

S11912-015-0460-2

P1433

Current Oncology Reports

P1476

Novel agents in mantle cell lymphoma.

@en

P2093

Anita Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

New molecular targets in mantle cell lymphoma

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

P2888

s11912-015-0460-2

P304

34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-015-0460-2

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037040657

http://www.w3.org/2001/XMLSchema#string

P698

26045130

http://www.w3.org/2001/XMLSchema#string